Rising biosimilar uptake touted amid ‘continuously evolving’ evidence for safety, efficacy
Canada could save an estimated $280 million a year in drug costs if biosimilar uptake here reached the levels seen in Norway, a speaker told…
- By: Glenn Kauth
- June 18, 2018 September 13, 2019
- 11:57












